AF
TYRA icon

Allworth Financial’s Tyra Biosciences TYRA Stock Holding History

Allworth Financial’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.98K Buy
104
+4
+4% +$129 ﹤0.01% 4081
2025
Q4 		$2.63K Hold
100
– – ﹤0.01% 4012
2025
Q3 		$1.4K Hold
100
– – ﹤0.01% 4154
2025
Q2 		$957 Hold
100
– – ﹤0.01% 3968
2025
Q1 		$1.01K Buy
+100
New +$1.29K ﹤0.01% 3464

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Allworth Financial's TYRA Position: Q1 2026 in Review

Allworth Financial increased its Tyra Biosciences (TYRA) stake by 4% in Q1 2026, buying an estimated $129 and bringing the position to 104 shares worth $3.98K. The position accounts for ﹤0.01% of the portfolio, ranked #4081.

Allworth Financial first reported a position in TYRA in Q1 2025 and has held it in 5 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Allworth Financial held 104 shares of Tyra Biosciences worth $3.98K as of Q1 2026.
  • Allworth Financial bought 4 Tyra Biosciences shares in Q1 2026, an estimated $129.
  • Tyra Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4081 holding.
  • Allworth Financial first reported a position in Tyra Biosciences in Q1 2025 and has held it in 5 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.